Total Payments
$1,068
2022 Payments
$20.08
Companies
23
Transactions
43
Medicare Patients
2,157
Medicare Billing
$378,857
Payment Breakdown by Category
Food & Beverage$913.55 (85.6%)
Research$139.09 (13.0%)
Gifts$15.00 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $913.55 | 41 | 85.6% |
| Unspecified | $139.09 | 1 | 13.0% |
| Gift | $15.00 | 1 | 1.4% |
Payments by Type
General
$928.55
42 transactions
Research
$139.09
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz North America, Inc. | $301.89 | 8 | $0 (2019) |
| Ipsen Biopharmaceuticals, Inc | $295.12 | 7 | $0 (2018) |
| Amgen Inc. | $65.98 | 3 | $0 (2018) |
| Allergan Inc. | $53.94 | 3 | $0 (2018) |
| Mitsubishi Tanabe Pharma America, Inc. | $27.11 | 2 | $0 (2018) |
| Scilex Pharmaceuticals Inc. | $25.61 | 2 | $0 (2019) |
| The Medicines Company | $25.56 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $25.37 | 2 | $0 (2019) |
| Flowonix Medical Incorporated | $24.76 | 1 | $0 (2018) |
| Arbor Pharmaceuticals, Inc. | $21.55 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $20.08 | 1 | C. R. Bard, Inc. & Subsidiaries ($20.08) |
| 2020 | $23.33 | 2 | Avanir Pharmaceuticals, Inc. ($11.93) |
| 2019 | $294.40 | 11 | Merz North America, Inc. ($195.84) |
| 2018 | $239.65 | 13 | Amgen Inc. ($65.98) |
| 2017 | $490.18 | 16 | Ipsen Biopharmaceuticals, Inc ($261.18) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/05/2022 | C. R. Bard, Inc. & Subsidiaries | — | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Medical Systems | ||||||
| 02/11/2020 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 01/28/2020 | Vertical Pharmaceuticals, LLC | — | Food and Beverage | In-kind items and services | $11.40 | General |
| 12/03/2019 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $21.79 | General |
| Category: MUSCULOSKELETAL | ||||||
| 11/19/2019 | Ultragenyx Pharmaceutical Inc. | CRYSVITA (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: XLH | ||||||
| 11/12/2019 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $12.36 | General |
| Category: Opioid Analgesic | ||||||
| 11/06/2019 | MERZ NORTH AMERICA, INC. | XEOMIN (Biological) | — | Cash or cash equivalent | $139.09 | Research |
| Study: PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF NT 201 IN THE TREATMENT OF LOWER LIMB SPASTICITY CAUSED BY STROKE OR TRAUMATIC BRAIN INJURY IN ADULT SUBJECTS, FOLLOWED BY AN OPEN LABEL EXTENSION WITH OR WITHOUT COMBINED UPPER LIMB TREATMENT • Category: MUSCULOSKELETAL | ||||||
| 10/22/2019 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $13.26 | General |
| Category: Musculoskeletal | ||||||
| 08/15/2019 | TerSera Therapeutics LLC | QMIIZ ODT (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: PAIN | ||||||
| 07/23/2019 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $20.86 | General |
| Category: MUSCULOSKELETAL | ||||||
| 07/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/21/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 04/16/2019 | Scilex Pharmaceuticals Inc. | ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Analgesic | ||||||
| 03/19/2019 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $14.10 | General |
| Category: MUSCULOSKELETAL | ||||||
| 11/14/2018 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/23/2018 | Scilex Pharmaceuticals Inc. | ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Analgesic | ||||||
| 09/25/2018 | Flowonix Medical Incorporated | Prometra II (Device) | Food and Beverage | Cash or cash equivalent | $24.76 | General |
| Category: Pain Management Pump | ||||||
| 08/21/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Neuroscience | ||||||
| 07/10/2018 | Mitsubishi Tanabe Pharma America, Inc. | Radicava (Drug) | Food and Beverage | Cash or cash equivalent | $14.98 | General |
| Category: Amyotrophic Lateral Sclerosis | ||||||
| 06/12/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Neuroscience | ||||||
| 04/24/2018 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Neurology | ||||||
| 04/12/2018 | Saol Therapeutics Inc. | Lioresal Intrathecal (baclofen injection) (Drug) | Gift | In-kind items and services | $15.00 | General |
| Category: Severe Spasticity | ||||||
| 04/03/2018 | AstraZeneca Pharmaceuticals LP | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Neuroscience | ||||||
| 02/27/2018 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $32.51 | General |
| Category: MUSCULOSKELETAL | ||||||
| 01/29/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF NT 201 IN THE TREATMENT OF LOWER LIMB SPASTICITY CAUSED BY STROKE OR TRAUMATIC BRAIN INJURY IN ADULT SUBJECTS, FOLLOWED BY AN OPEN LABEL EXTENSION WITH OR WITHOUT COMBINED UPPER LIMB TREATMENT | MERZ NORTH AMERICA, INC. | $139.09 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 652 | 1,863 | $349,162 | $125,747 |
| 2022 | 7 | 719 | 1,980 | $339,540 | $111,254 |
| 2021 | 5 | 562 | 1,731 | $295,833 | $106,159 |
| 2020 | 7 | 224 | 577 | $158,526 | $35,696 |
Total Patients
2,157
Total Services
6,151
Medicare Billing
$378,857
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 331 | 1,510 | $241,600 | $91,392 | 37.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 130 | 137 | $36,990 | $11,955 | 32.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 115 | 121 | $38,841 | $11,739 | 30.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 46 | $20,608 | $6,160 | 29.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 32 | 49 | $11,123 | $4,502 | 40.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 334 | 1,408 | $225,274 | $75,930 | 33.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 111 | 117 | $37,556 | $11,923 | 31.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 115 | 121 | $32,670 | $9,576 | 29.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 67 | 232 | $22,735 | $6,804 | 29.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 46 | 47 | $9,870 | $3,590 | 36.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 34 | 35 | $6,895 | $1,880 | 27.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 20 | $4,540 | $1,550 | 34.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 303 | 1,454 | $221,008 | $81,124 | 36.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 110 | 119 | $36,295 | $12,556 | 34.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 116 | 125 | $32,125 | $10,235 | 31.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 18 | 18 | $3,600 | $1,407 | 39.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 15 | 15 | $2,805 | $837.60 | 29.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 59 | 310 | $85,560 | $19,361 | 22.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 76 | 158 | $23,700 | $5,301 | 22.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 24 | 24 | $18,624 | $4,208 | 22.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 30 | $12,630 | $2,719 | 21.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 19 | 26 | $7,462 | $1,707 | 22.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 18 | 18 | $7,470 | $1,696 | 22.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 11 | 11 | $3,080 | $703.59 | 22.8% |
About Dr. Jayne Donovan, M.D
Dr. Jayne Donovan, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1407172794.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jayne Donovan, M.D has received a total of $1,068 in payments from pharmaceutical and medical device companies, with $20.08 received in 2022. These payments were reported across 43 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($913.55).
As a Medicare-enrolled provider, Donovan has provided services to 2,157 Medicare beneficiaries, totaling 6,151 services with total Medicare billing of $378,857. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Spinal Cord Injury Medicine
- Location Charleston, SC
- Active Since 04/13/2010
- Last Updated 03/19/2021
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1407172794
Products in Payments
- Dysport 300 U-1 (Drug) $261.18
- XEOMIN (Biological) $228.35
- Xeomin (Biological) $73.54
- BOTOX NEURO REHAB (Drug) $41.94
- Dysport (Drug) $33.94
- Prolia (Biological) $33.75
- Aimovig (Biological) $32.23
- Radicava (Drug) $27.11
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $25.61
- IONSYS (Drug) $25.56
- XARELTO (Drug) $25.37
- Prometra II (Device) $24.76
- Horizant (Drug) $21.55
- BUTRANS (Drug) $21.30
- Proclaim Family of SCS IPGs (Device) $20.36
- HYMOVIS (Device) $18.84
- Lioresal Intrathecal (baclofen injection) (Drug) $15.00
- MOVANTIK (Drug) $15.00
- CRYSVITA (Drug) $14.14
- QMIIZ ODT (Drug) $14.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Charleston
Sarah Breevoort, Md/Phd, MD/PHD
Physical Medicine & Rehabilitation — Payments: $89,122
Physical Medicine & Rehabilitation $89,122
Dr. Ameet Nagpal, Md, Ms, MD, MS
Physical Medicine & Rehabilitation — Payments: $10,129
Physical Medicine & Rehabilitation $10,129
Emily Darr, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $4,527
Physical Medicine & Rehabilitation $4,527
David Morrow
Physical Medicine & Rehabilitation — Payments: $2,937
Physical Medicine & Rehabilitation $2,937
Dr. Juan Robles, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $2,741
Physical Medicine & Rehabilitation $2,741
Dr. James Keffer, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $1,929
Physical Medicine & Rehabilitation $1,929